PrevenTest > For Providers

Tumor Molecular Testing > For Neuroblastoma / Medulloblastoma Cancer

 

The Time Is Now

Personalized Treatment Designed For Cancer Patients

Neuroblastoma and Medulloblastoma Cancer Panel

Neurobalstoma accounts for 15% of all pediatric cancer deaths in the United Stated. Medulloblastoma accounts for 15-20% of all pediatric brain tumors. Both diseases are characterized by aggressive, invasive, and deadly nature. People with familial cancer syndromes are at a higher risk to develop brain carcinoma. 

Genes and Their Locations

ALK

2p23.1

MGMT1

10q26.3

ERCC1

19q13.32

TOPO1

20q12

PTCH1

9q22.3

TP53

17p13.1

RRM1

11p15.4

PGP

16p13.3

SMO

7q32.1

CTNNB1

3p22.1

1p19q

co-deletion